Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Nordea Investment Management AB

Nordea Investment Management AB lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 14.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,001 shares of the biotechnology company's stock after selling 1,686 shares during the period. Nordea Investment Management AB's holdings in Axon Enterprise were worth $5,960,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Victory Capital Management Inc. boosted its position in Axon Enterprise by 0.8% in the 2nd quarter. Victory Capital Management Inc. now owns 42,576 shares of the biotechnology company's stock valued at $12,528,000 after buying an additional 326 shares during the period. Private Advisor Group LLC boosted its holdings in shares of Axon Enterprise by 5.8% in the second quarter. Private Advisor Group LLC now owns 10,339 shares of the biotechnology company's stock valued at $3,045,000 after purchasing an additional 571 shares during the period. Quest Partners LLC grew its stake in Axon Enterprise by 98,200.0% in the second quarter. Quest Partners LLC now owns 983 shares of the biotechnology company's stock worth $289,000 after purchasing an additional 982 shares in the last quarter. Wedbush Securities Inc. increased its holdings in Axon Enterprise by 2.4% during the 2nd quarter. Wedbush Securities Inc. now owns 2,148 shares of the biotechnology company's stock worth $632,000 after purchasing an additional 51 shares during the period. Finally, Royal London Asset Management Ltd. increased its holdings in Axon Enterprise by 5.0% during the 2nd quarter. Royal London Asset Management Ltd. now owns 26,574 shares of the biotechnology company's stock worth $7,819,000 after purchasing an additional 1,266 shares during the period. Institutional investors own 79.08% of the company's stock.

Analysts Set New Price Targets

AXON has been the topic of a number of recent research reports. JMP Securities increased their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a "market outperform" rating in a research report on Thursday, October 31st. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday. They set a "buy" rating and a $700.00 target price on the stock. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a research report on Monday, November 11th. Finally, Morgan Stanley raised shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and increased their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $504.92.

Axon Enterprise Stock Performance

Shares of AXON stock traded down $7.34 during mid-day trading on Friday, reaching $570.00. The stock had a trading volume of 480,928 shares, compared to its average volume of 762,025. Axon Enterprise, Inc. has a 1-year low of $246.99 and a 1-year high of $698.67. The firm has a market cap of $43.47 billion, a price-to-earnings ratio of 147.29, a PEG ratio of 14.19 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The business's fifty day moving average is $604.40 and its 200-day moving average is $446.90.

Insider Activity

In related news, Director Michael Garnreiter sold 1,000 shares of the business's stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares of the company's stock, valued at approximately $11,500,916.82. The trade was a 3.67 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company's stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 51,545 shares of company stock valued at $31,159,317 in the last quarter. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.